Join us for an exclusive webinar where we delve into the dynamic and expansive German healthcare market—the largest healthcare and life sciences market in Europe. Discover why Germany’s healthcare expenditures are the highest in Europe and explore the latest market data, trends, and developments shaping this vital sector. This webinar is tailored for international companies eager to understand the opportunities within the German healthcare landscape. Whether you’re looking to export, invest, expand, or simply stay informed, this session will provide valuable knowledge and actionable insights.
 

 
What You’ll Learn:

• Comprehensive market data and insights
• Current trends and emerging developments relevant for market access
• Key subsectors driving growth

 
This session is organized by GLOBE – Global Life Sciences Opportunities Business Exchange, an Intellectual Exchange Group with the North Carolina Biotechnology Center. GLOBE partners include the U.S. Commercial Service, Small Business & Technology Development Center, and the Economic Development Partnership of North Carolina.
 
Panelists:
Nadine Litchfield is Senior Manager Healthcare at Germany Trade and Invest (GTAI), the foreign trade and inward investment agency of the Federal Republic of Germany. Nadine has been with GTAI since 2012, assisting numerous companies from various industries with their investment plans for Germany. Prior to her role at GTAI, she assisted German, Dutch and US companies with their entry into the US respective European market and served as Authorized Trade Representative of the Commonwealth of Pennsylvania for the Netherlands and Belgium.
 
Michael Weisser, CEO of AiM (an IGES Group company), has been working at AiM for 16 years, providing consultancy services to industry. His focus is on market access and reimbursement of diagnostic and therapeutic procedures that are based on the use of medical devices, IVD and digital products. This involves setting up strategies and implementing them hands-on in the European and specifically German context.
 
Tilo Mandry, Lead International Liaison Manager, IGES Institut, Berlin. Tilo conducts comparative studies on international health systems and reimbursement and pricing procedures for innovative therapies. His focus is on advanced therapies, combinations of drugs and medical devices, digital health applications and orphan drugs. He studied law at the University of Cologne and Vanderbilt University and received his PhD from the Philipps-University of Marburg.